SCHEMBL24121997

SCHEMBL24121997

Cc1ccnn2c(C)nnc12

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
RXFP1 Q9HBX9 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
TSHR P16473 2/20 0.36
MAPK1 P28482 1/20 0.36
HSD17B10 Q99714 1/20 0.36
CYP17A1 P05093 7/20 0.33
CYP1A2 P05177 2/20 0.33
BRD4 O60885 2/20 0.32
GABRA1 P14867 1/20 0.32
GABRG2 P18507 1/20 0.32
GABRB3 P28472 1/20 0.32
GABRA5 P31644 1/20 0.32
GABRA3 P34903 1/20 0.32
GABRA2 P47869 1/20 0.32
SMN1; SMN2 Q16637 3/20 0.32
LMNA P02545 1/20 0.32
BRD2 P25440 1/20 0.31
BRD3 Q15059 1/20 0.31
HTT P42858 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18521190 0.79 RXFP1 (0.36) RXFP1L3MBTL1TSHRMAPK1HSD17B10
Bromide SCHEMBL16494617 0.78 NOS3 (0.32) CYP17A1CYP1A2
SCHEMBL6619651 0.76 RXFP1 (0.34) RXFP1L3MBTL1TSHRMAPK1HSD17B10
SCHEMBL1664963 0.75 SMN1; SMN2 (0.50) RXFP1L3MBTL1TSHRHSD17B10CYP17A1
SCHEMBL9691041 0.71 RAB9A (0.36) HSD17B10CYP17A1CYP1A2SMN1; SMN2LMNA
SCHEMBL9691174 0.71 CYP17A1 (0.49) L3MBTL1TSHRMAPK1HSD17B10CYP17A1
SCHEMBL27447606 0.70 ALDH1A1 (0.39) TSHRHSD17B10CYP17A1CYP1A2SMN1; SMN2
SCHEMBL9689135 0.70 CYP17A1 (0.48) RXFP1L3MBTL1TSHRHSD17B10CYP17A1
SCHEMBL27360285 0.70 GABRA1 (0.38) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL27389545 0.69 PDE9A (0.36) MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021254493-A1 CYCLIC COMPOUND HAVING ANTI-TUMOR ACTIVITY AND USE THEREOF 上海翊石医药科技有限公司 2021-12-23 WO disclosed